Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alessandro Rizzo MD"'
Autor:
Alessandro Rizzo MD, Antonio Cusmai MD, Raffaella Massafra PhD, Samantha Bove PhD, Maria Colomba Comes PhD, Annarita Fanizzi PhD, Gennaro Gadaleta-Caldarola MD, Donato Oreste MD, Alfredo Zito MD, Francesco Giotta MD, Vito Lorusso MD, Gennaro Palmiotti MD
Publikováno v:
Cancer Control, Vol 29 (2022)
Epidermal growth factor receptor 2 (EGFR2, also known as HER2) overexpression and/or amplification confers a more aggressive clinical behavior but also represents a therapeutic opportunity for targeted therapies in breast cancer (BC). Over the last 2
Externí odkaz:
https://doaj.org/article/360c03889f5c4df8bfe1bc8d24c80f02
Autor:
Alessandro Rizzo MD, Alessandro Di Federico MD, Angela Dalia Ricci MD, Giorgio Frega MD, Andrea Palloni MD, Rachele Pagani MD, Simona Tavolari MD, Mariacristina Di Marco MD, Giovanni Brandi MD
Publikováno v:
Cancer Control, Vol 27 (2020)
Background: Biliary tract cancers (BTCs) represent a heterogeneous group of aggressive solid tumors with limited therapeutic options, and include gallbladder cancer (GBC), ampulla of Vater cancer (AVC), intrahepatic cholangiocarcinoma (iCCA) and extr
Externí odkaz:
https://doaj.org/article/fe81824e539548d1b7904ee5b967f7ec
Autor:
Salati M; Massimiliano Salati, MD, Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy; PhD Program Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy; and Alessandro Rizzo, MD, Struttura Semplice Dipartimentale di Oncologia Medica per la presa in carico globale del paziente oncologico 'Don Tonino Bello,' IRCCS Istituto Tumori 'Giovanni Paolo II,' Bari, Italy., Rizzo A; Massimiliano Salati, MD, Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy; PhD Program Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy; and Alessandro Rizzo, MD, Struttura Semplice Dipartimentale di Oncologia Medica per la presa in carico globale del paziente oncologico 'Don Tonino Bello,' IRCCS Istituto Tumori 'Giovanni Paolo II,' Bari, Italy.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Apr 20; Vol. 40 (12), pp. 1389-1390. Date of Electronic Publication: 2022 Mar 02.
Autor:
Rizzo A; Alessandro Rizzo, MD, Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico 'Don Tonino Bello', I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy and Giovanni Brandi, MD, PhD, Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy., Brandi G; Alessandro Rizzo, MD, Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico 'Don Tonino Bello', I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy and Giovanni Brandi, MD, PhD, Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2022 Mar; Vol. 6, pp. e2100511.